Findings from a retrospective comparison of data from prospective studies of presbyopia-correcting IOLs highlight the performance similarities and differences of different technologies.
Cheryl Guttman Krader
Progress occurring on several fronts is creating optimism that retinal ganglion cell (RGC) replacement may become a reality for preserving or restoring vision in patients with glaucoma, according to Jeffrey L. Goldberg, MD, PhD.
A novel extended-depth-of-focus (EDOF) IOL (Mini WELL IOL, SIFI Medtech) is providing very favorable functional and safety outcomes that correspond with a high degree of patient satisfaction, according to data collected by ophthalmologist
As more microinvasive glaucoma surgery (MIGS) procedures become available, surgeons are faced with decisions on adoption of new techniques.
Research aiming to elucidate the underlying factors for oxidative damage to the trabecular meshwork in glaucoma has led to studies of alterations in gene expression that may ultimately guide the development of genetic therapy for glaucoma, said Carla J. Siegfried, MD, recipient of the 2018 Shaffer Prize for Innovative Glaucoma Research.
A micro-interventional device that uses a nitinol filament can dissect any grade cataract without causing capsular stress.
Customized corneal crosslinking for keratoconus focuses the treatment on the weak area of the cornea.
Achieving satisfaction for patients interested in a multifocal IOL begins with comprehensive preoperative screening and evaluation.